CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Expression of the autophagic protein ATG4B, a component of the LC3 autophagosome system, was higher in CD34+ cells from CML patients, and expression differed between patients prior to therapy with TKIs as well as responders and non-responders to imatinib treatment54.